Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksMANKIND
resources
MANKIND

Mankind Pharma Ltd.

NSE: MANKIND
BSE: 543904
Sector: Healthcare
Industry: Pharmaceuticals
2,365.00-9.5 (-0.40%)
25 Aug, 3:30 PM

Annual Reports and Financial Documents

Mankind Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Mankind Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General22 Aug 2026
    Intimation Regarding ESG Rating
    Please find attached intimation regarding ESG Rating
  2. Press Release / Media Release20 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Please find attached press release dated August 20, 2026.
  3. Newspaper Publication19 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached Newspaper Advertisement of Notice of Postal Ballot
  4. Postal Ballot18 Aug 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Please find attched postal ballot notice
  5. General17 Aug 2026
    Completion Of Realignment Of Security Cover In Respect Of Non-Convertible Debentures And Consequent Release Of Pledged Shares Of Bharat Serums And Vaccines Limited
    Completion of realignment of Security Cover in respect of Non-Convertible Debentures.
  6. Acquisition13 Aug 2026
    Announcement under Regulation 30 (LODR)-Updates on Acquisition
    Please find attached intimation regarding incorporation of a wholly owned subsidiary company in Netherlands
  7. Change in Management10 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Please find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
  8. Change in Management10 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Please find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
  9. Outcome without intimation10 Aug 2026
    Board Meeting Outcome for For Appointment Of An Additional Director Designated As Non-Executive Independent Director
    Please find attached outcome of board meeting
  10. Analyst / Investor Meet10 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Please find attached intimation regarding participation in Investor Conferences
  11. AGM6 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Please find attached Voting Results and Scrutinizer''s Report of 35th AGM
  12. AGM4 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Please find attached proceedings of the 35th AGM of the Company
  13. Newspaper Publication31 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached Newspaper Advertisement - Unaudited Financial Results of the company for the quarter ended on June 30, 2026
  14. Analyst / Investor Meet30 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Investor Conference call for Q1FY27 - Audio Recording
  15. Reg. 54 - Asset Cover details30 Jul 2026
    Compliances-Reg. 54 - Asset Cover details
    Please find attached certificate under Regulation 54 of the SEBI (LODR) Regulations, 2015
  16. Press Release / Media Release30 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Please find attached press release on financial results of the Company for Q1FY27
  17. General30 Jul 2026
    Approval For Issuance Of Corporate Guarantee
    Board of Directors of the Company in its meeting held today has inter-alia considered and approved the issuance of corproate guarantee in favour of Bharat Serums & Vaccines Limited, a WOS.
  18. Outcome of Board Meeting30 Jul 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board Meeting
  19. General27 Jul 2026
    Final Update On Stake Sale Of Broadway Hospitality Services Private Limited
    Intimation under Regulation 30 of the SEBI LODR
  20. Analyst / Investor Meet17 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Please find attached intimation regarding investor conference call for Q1FY27.

Frequently Asked Questions

Where can I download the annual report of Mankind Pharma Ltd.?
Annual reports of Mankind Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Mankind Pharma Ltd.?
Quarterly earnings results and presentations of Mankind Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Mankind Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Mankind Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Mankind Pharma Ltd.?
Investor presentations and annual day presentations of Mankind Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Mankind Pharma Ltd.?
Corporate announcements and regulatory filings of Mankind Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Mankind Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Mankind Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Mankind Pharma Ltd.?
The ISIN (International Securities Identification Number) of Mankind Pharma Ltd. is INE634S01028. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Mankind Pharma Ltd. listed?
Mankind Pharma Ltd. is listed on NSE and BSE. The NSE symbol is MANKIND and the BSE code is -.
Where can I find the shareholding pattern of Mankind Pharma Ltd.?
The quarterly shareholding pattern of Mankind Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Mankind Pharma Ltd. on Sharpely?
Share price data for Mankind Pharma Ltd. is updated as of 25 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.